文献速递肿瘤 PET/CT骨显像与常规 SPECT

复合预测评分用于解读激素敏感性前列腺癌患者[18F]PSMA-1007 PET/CT中的骨局灶性摄取

Composite Prediction Score to Interpret Bone Focal Uptake in Hormone-Sensitive Prostate Cancer Patients Imaged with [18F]PSMA-1007 PET/CT.
PubMed 文献 · J Nucl Med · 2024-10-01

本研究回顾性分析3个三级癌症中心及1个外部验证中心的激素敏感性前列腺癌患者[18F]PSMA-1007 PET/CT,评估临床、生化及影像参数组合能否预测骨局灶性摄取为骨转移。共识别448个骨局灶性摄取标本,188个(41.9%)为前列腺癌转移;基于ADT状态、SUVmax和HUmean构建的BUMP评分AUC为0.87,外部验证AUC为0.92,在经验较少的读片者中特异性优于视觉评估(88% vs 54%,P<0.001)。

要点

  • BUMP评分可准确区分骨转移与良性非特异性骨摄取,AUC为0.87。
  • 外部验证中BUMP评分AUC为0.92,决策曲线分析显示净获益更高。
  • 经验较少读片者使用BUMP评分特异性88% vs 视觉评估54%,P<0.001。

核心结论

  • BUMP评分能准确区分前列腺癌患者[18F]PSMA-1007 PET骨局灶性摄取中的骨转移与良性非特异性骨摄取,相比单纯评估CT成骨性改变提供额外价值。

研究设计与样本

  • 回顾性分析3个三级癌症中心的激素敏感性前列腺癌患者[18F]PSMA-1007 PET/CT,第4个中心参与外部验证。
  • 共识别267例患者的448个骨[18F]PSMA-1007局灶性摄取标本,其中188个(41.9%)对应前列腺癌转移。
  • 外部验证纳入89个骨摄取标本,其中51%为转移。

主要发现

  • PET/CT时正在接受雄激素剥夺治疗(P<0.001)、SUVmax(P<0.001)和HUmean(P<0.001)独立预测骨转移。
  • BUMP评分AUC为0.87,经10折内部验证和外部验证(n=89骨摄取,51%转移)AUC为0.92。
  • BUMP评分AUC显著高于HUmean(AUC 0.62),在HUmean位于第一三分位的病灶中AUC仍高达0.80。
  • 决策曲线分析显示BUMP评分净获益更高。
  • 与视觉评估相比,BUMP评分在经验较少的PET读片者中提供额外特异性价值(88% vs 54%,P<0.001)。

关键数值与推荐

  • BUMP评分基于PET/CT时是否正在接受雄激素剥夺治疗、SUVmax和HUmean构建。
  • BUMP评分AUC为0.87,外部验证AUC为0.92。
  • HUmean的AUC为0.62,BUMP评分在HUmean第一三分位病灶中AUC为0.80。
  • 经验较少读片者使用BUMP评分特异性88% vs 视觉评估54%,P<0.001。

临床怎么用

  • 作者认为BUMP评分有助于临床医生解读影像结果,尤其对经验较少的读片者,可能降低患者过度分期的风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Unspecific bone uptake (UBU) related to [18F]PSMA-1007 PET/CT imaging represents a clinical challenge. We aimed to assess whether a combination of clinical, biochemical, and imaging parameters could predict skeletal metastases in patients with [18F]PSMA-1007 bone focal uptake, aiding in result interpretation. Methods: We retrospectively analyzed [18F]PSMA-1007 PET/CT performed in hormone-sensitive prostate cancer (PCa) patients at 3 tertiary-level cancer centers. A fourth center was involved in performing an external validation. For each, a volume of interest was drawn using a threshold method to extract SUVmax, SUVmean, PSMA tumor volume, and total lesion PSMA. The same volume of interest was applied to CT images to calculate the mean Hounsfield units (HUmean) and maximum Hounsfield units. Clinical and laboratory data were collected from electronic medical records. A composite reference standard, including follow-up histopathology, biochemistry, and imaging data, was used to distinguish between PCa bone metastases and UBU. PET readers with less (n = 2) or more (n = 2) experience, masked to the reference standard, were asked to visually rate a subset of focal bone uptake (n = 178) as PCa metastases or not. Results: In total, 448 bone [18F]PSMA-1007 focal uptake specimens were identified in 267 PCa patients. Of the 448 uptake samples, 188 (41.9%) corresponded to PCa metastases. Ongoing androgen deprivation therapy at PET/CT (P < 0.001) with determination of SUVmax (P < 0.001) and HUmean (P < 0.001) independently predicted bone metastases. A composite prediction score, the bone uptake metastatic probability (BUMP) score, achieving an area under the receiver-operating-characteristic curve (AUC) of 0.87, was validated through a 10-fold internal and external validation (n = 89 bone uptake, 51% metastatic; AUC, 0.92). The BUMP score's AUC was significantly higher than that of HUmean (AUC, 0.62) and remained high among lesions with HUmean in the first tertile (AUC, 0.80). A decision-curve analysis showed a higher net benefit with the score. Compared with the visual assessment, the BUMP score provided added value in terms of specificity in less-experienced PET readers (88% vs. 54%, P < 0.001). Conclusion: The BUMP score accurately distinguished UBU from bone metastases in PCa patients with [18F]PSMA-1007 focal bone uptake at PET imaging, offering additional value compared with the simple assessment of the osteoblastic CT correlate. Its use could help clinicians interpret imaging results, particularly those with less experience, potentially reducing the risk of patient overstaging.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Bauckneht M, D'Amico F, Albano D, et al. Composite Prediction Score to Interpret Bone Focal Uptake in Hormone-Sensitive Prostate Cancer Patients Imaged with [18F]PSMA-1007 PET/CT. J Nucl Med. 2024. PMID: 39237346. doi:10.2967/jnumed.124.267751

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。